California State Teachers Retirement System (CalSTRS)’s Asterias Biotherapeutics Inc. Series A AST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-46,632
Closed -$68K 3157
2018
Q1
$68K Hold
46,632
﹤0.01% 2945
2017
Q4
$105K Buy
46,632
+2,268
+5% +$5.74K ﹤0.01% 2924
2017
Q3
$151K Sell
44,364
-3,400
-7% -$11.4K ﹤0.01% 2928
2017
Q2
$170K Buy
47,764
+2,100
+5% +$6.92K ﹤0.01% 2950
2017
Q1
$155K Sell
45,664
-1,000
-2% -$3.89K ﹤0.01% 2872
2016
Q4
$215K Sell
46,664
-700
-1% -$2.89K ﹤0.01% 2849
2016
Q3
$201K Sell
47,364
-200
-0.4% -$647 ﹤0.01% 2866
2016
Q2
$114K Buy
47,564
+25,447
+115% +$92K ﹤0.01% 2970
2016
Q1
$104K Buy
22,117
+2,733
+14% +$10.6K ﹤0.01% 2916
2015
Q4
$76K Buy
19,384
+300
+2% +$1.38K ﹤0.01% 2982
2015
Q3
$74K Hold
19,084
﹤0.01% 2999
2015
Q2
$88K Buy
+19,084
New +$183K ﹤0.01% 2990

Other funds holding AST

California State Teachers Retirement System (CalSTRS)'s AST Position: Q2 2018 in Review

California State Teachers Retirement System (CalSTRS) sold out of Asterias Biotherapeutics Inc. Series A (AST) in Q2 2018, closing a stake of 46,632 shares — an estimated $68K sold.

California State Teachers Retirement System (CalSTRS) first reported a position in AST in Q2 2015 and held it in 12 quarters. The position peaked at $215K in Q4 2016. 62 funds tracked by Wall St. Rank hold AST as of Q2 2018.

  • California State Teachers Retirement System (CalSTRS) reported no remaining Asterias Biotherapeutics Inc. Series A position as of Q2 2018 after selling out during the quarter.
  • California State Teachers Retirement System (CalSTRS) sold 46,632 Asterias Biotherapeutics Inc. Series A shares in Q2 2018, an estimated $68K.
  • California State Teachers Retirement System (CalSTRS) first reported a position in Asterias Biotherapeutics Inc. Series A in Q2 2015 and held it in 12 quarters.
  • California State Teachers Retirement System (CalSTRS)'s Asterias Biotherapeutics Inc. Series A position peaked at $215K in Q4 2016.
  • 62 funds tracked by Wall St. Rank held Asterias Biotherapeutics Inc. Series A as of Q2 2018.

Based on California State Teachers Retirement System (CalSTRS)'s 13F filing for Q2 2018, filed 14 Aug 2018.